Documentation Centre

 

 

  of 251 Next page

Go to page: of

Screenshot Date Categories Title Author Format
Adiposity significantly modifies genetic risk for dyslipidemia. J Lipid Res. 2014;55:2416-22 February 19, 2015 Adiposity significantly modifies genetic risk for dyslipidemia. J Lipid Res. 2014;55:2416-22 Cole CB, Nikpay M, Lau P, Stewart AF, Davies RW, Wells GA, Dent R, McPherson R Key Publications
Distinct developmental profile of lower-body adipose tissue defines resistance against obesity-associated metabolic complications. Diabetes. 2014;63:3785-97 February 16, 2015 Distinct developmental profile of lower-body adipose tissue defines resistance against obesity-associated metabolic complications. Diabetes. 2014;63:3785-97 Pinnick KE, Nicholson G, Manolopoulos KN, McQuaid SE, Valet P, Frayn KN, Denton N, Min JL, Zondervan KT, Fleckner J; MolPAGE Consortium, McCarthy MI, Holmes CC, Karpe F Key Publications
Does the quality of subcutaneous adipose tissue have implications regarding the way we assess and manage obesity? February 11, 2015 Does the quality of subcutaneous adipose tissue have implications regarding the way we assess and manage obesity? Fredrik Karpe, PhD, FRCP, Professor, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK Expert Opinions
Video 0:40 min.
(3 MB)
Adipose tissue n-3 fatty acids and metabolic syndrome. Eur J Clin Nutr. 2015;69:114-20 February 09, 2015 Adipose tissue n-3 fatty acids and metabolic syndrome. Eur J Clin Nutr. 2015;69:114-20 Cespedes E, Baylin A, Campos H Key Publications
Could you comment on the adipogenic potential of subcutaneous adipose tissue as it relates to health? January 28, 2015 Could you comment on the adipogenic potential of subcutaneous adipose tissue as it relates to health? André Tchernof, PhD, Department of Nutrition, Université Laval, Endocrinology and Genomics axis, Laval University Medical Centre, Québec, QC, Canada Expert Opinions
Video 0:47 min.
(4 MB)
Epidemiology: obesity and cancer--the evidence is fattening up. Nat Rev Endocrinol. 2014;10:644-5 January 26, 2015 Epidemiology: obesity and cancer--the evidence is fattening up. Nat Rev Endocrinol. 2014;10:644-5 Kaaks R, Kühn T Key Publications
Increased cardiometabolic risk factors and inflammation in adipose tissue in obese subjects classified as metabolically healthy. Diabetes Care. 2014;37:2813-21 January 13, 2015 Increased cardiometabolic risk factors and inflammation in adipose tissue in obese subjects classified as metabolically healthy. Diabetes Care. 2014;37:2813-21 Gómez-Ambrosi J, Catalán V, Rodríguez A, Andrada P, Ramírez B, Ibáñez P, Vila N, Romero S, Margall MA, Gil MJ, Moncada R, Valentí V, Silva C, Salvador J, Frühbeck G Key Publications
Effect of 8 weeks of overfeeding on ectopic fat deposition and insulin sensitivity: testing the "adipose tissue expandability" hypothesis. Diabetes Care. 2014;37:2789-97 January 12, 2015 Effect of 8 weeks of overfeeding on ectopic fat deposition and insulin sensitivity: testing the "adipose tissue expandability" hypothesis. Diabetes Care. 2014;37:2789-97 Johannsen DL, Tchoukalova Y, Tam CS, Covington JD, Xie W, Schwarz JM, Bajpeyi S, Ravussin E Key Publications
Obesity: Targeting fat deposits-one step closer. Nat Rev Endocrinol. 2014;10(10):576 December 23, 2014 Obesity: Targeting fat deposits-one step closer. Nat Rev Endocrinol. 2014;10(10):576 Holmes D Key Publications
Could you elaborate on how you see the role of subcutaneous adipose tissue capacity for hyperplasia in cardiometabolic health? December 19, 2014 Could you elaborate on how you see the role of subcutaneous adipose tissue capacity for hyperplasia in cardiometabolic health? Fredrik Karpe, PhD, FRCP, Professor, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK Expert Opinions
Video 0:49 min.
(4 MB)

  of 251 Next page

Go to page: of